Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3 quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-44-3-liebowitz
Categories:
Psychopharmacology Bulletin
,
VOL 44 No. 3 Articles
Tags:
adverse-event
,
antidepressant-induced-suicidality
,
antidepressant-tolerability
,
carol-r-reed
,
daniel-k-kajdasz
,
harry-a-croft
,
heidi-whalen
,
maria-athanasiou
,
medworks-media
,
michael-liebowitz
,
psychopharmacology-bulletin
,
sexual-side-effects
,
susan-gallipoli
,
treatment-emergent-adverse-event
,
volume-44
,
weight-gain
Description
Description
ORIGINAL RESEARCH
The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder
Michael Liebowitz, Harry A. Croft, Daniel K. Kajdasz, Heidi Whalen, Susan Gallipoli, Maria Athanasiou, Carol R. Reed
PB-44-3-2011-Liebowitz
Related products
Clozapine Related Suicidal Obsession by Branka Aukst-Margetic
$
30.00
Add to cart
Details
Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Page load link
Go to Top